Driving the Next Generation of Endocrinology Care
Crinetics Pharmaceuticals is a global biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics for endocrine diseases and endocrine-related tumors, including acromegaly and Cushing's disease. Its proprietary nonpeptide small-molecule platform has produced multiple clinical-stage candidates, including paltusotine (oral SST2 agonist) and atumelnant (oral ACTH antagonist). Founded in San Diego, the company is publicly traded on Nasdaq (CRNX) and has approximately 500–1,000 employees.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2026
Mar 2018
Nov 2015
Create a free account to see which investors have funded this company.
Create Free Account
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Health insurance company using technology to make health care simple, affordable, and accessible.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
